Executive Summary

In this report, we examine some of the latest technology in healthcare, such as gene editing and gene therapy, personal genomics, nanomedicine, organs-on-chips, regenerative medicine and other trends, such as wearable technology and robotics. These are some key findings:

• The global digital healthcare market was worth US$60.8 billion in 2013, and is estimated to grow to US$135.9 billion in 2017 and reach nearly US$233.3 billion in 2020.
• There are some 4,000 diseases linked to genetic dysfunction. Conventional drugs do not work for about 75% of cancer (a genetic disease) patients, on average.
• The global nanomedicine market was worth US$248 billion in 2014, and is projected to grow at a CAGR of 16.3% to reach US$528 billion in 2019.
• The market for organs-on-chips was worth some US$31.5 million in 2015, and growth is expected to surge at a CAGR of 70% by 2020.
• New developments in healthcare must solve the problems that patients and healthcare professionals face regularly, in order to become economically viable and successful.
• They also need to get through the long stages of clinical trials and gain regulatory approvals faster, in order to be available to the mass market.